cytarabine has been researched along with (3,4-dihydroxyphenylamino)-2-imidazoline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cecconi, F; D'Sa, C; Flavell, RA; Klocke, BJ; Korsmeyer, SJ; Lindsten, T; Roth, KA; Thompson, CB | 1 |
1 other study(ies) available for cytarabine and (3,4-dihydroxyphenylamino)-2-imidazoline
Article | Year |
---|---|
Caspase regulation of genotoxin-induced neural precursor cell death.
Topics: Aging; Animals; Apoptotic Protease-Activating Factor 1; bcl-2 Homologous Antagonist-Killer Protein; Blotting, Western; Caspases; Catecholamines; Cell Death; Cells, Cultured; Cytarabine; DNA Damage; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Female; Imidazolines; Immunohistochemistry; Immunosuppressive Agents; Membrane Proteins; Mice; Mice, Inbred Strains; Mice, Knockout; Mutagens; Neurons; Pregnancy; Proteins; Reactive Oxygen Species; Telencephalon; Tumor Suppressor Protein p53; X-Rays | 2003 |